SIDISI

SiDiSi Biotech is a French biotechnology company specializing in the development of innovative drug delivery systems based on silicon-diamond-silicon (SiDiSi) nanoparticles. The company's proprietary platform utilizes porous silicon and diamond-like carbon structures to encapsulate and protect therapeutic agents, enabling controlled and targeted release. This technology is designed to improve the bioavailability and safety profile of various drugs, particularly in the fields of oncology and infectious diseases. By leveraging its unique material science expertise, SiDiSi Biotech aims to overcome traditional barriers in drug delivery, such as poor solubility and systemic toxicity. The company is currently focused on pre-clinical validation of its lead programs and establishing strategic partnerships with pharmaceutical firms.